Definium Therapeutics(DFTX)今日发布重磅消息:其针对广泛性焦虑障碍的DT120 Odt,在3期Voyage研究中录得积极的顶线数据。该研究结果令人振奋,为这款在研疗法带来了新曙光。
Definium Therapeutics(DFTX)今日发布重磅消息:其针对广泛性焦虑障碍的DT120 Odt,在3期Voyage研究中录得积极的顶线数据。该研究结果令人振奋,为这款在研疗法带来了新曙光。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.